---
title: "U.S. Funds Moderna for H5N1 Vaccine Development"
description: "U.S. Funds Moderna for H5N1 Vaccine Development"

---


:::info

"Informed AI News" is an publications aggregation platform, ensuring you only gain the most valuable information, to eliminate information asymmetry and break through the limits of information cocoons.  [Find out more >>](/)

:::

# U.S. Funds Moderna for H5N1 Vaccine Development

import Tabs from '@theme/Tabs';
import TabItem from '@theme/TabItem';

<Tabs
	defaultValue="summary"
	values={[
	{label: 'summary', value: 'summary'},
	{label: 'score', value: 'score'},
]}>
<TabItem value="summary">


U.S. awards Moderna $176 million for bird flu vaccine development. Funds aim to finalize testing and production of an mRNA-based vaccine against H5N1 avian influenza. Concerns rise over H5N1 outbreaks in dairy cows and human infections. Moderna's mRNA technology, used in COVID-19 vaccines, promises faster development and production. Risk of bird flu pandemic looms if virus mutates to spread among people.
</TabItem>
<TabItem value="score">
	| Scores     | Value   | Explanation |
	| -------- | ------- | ------- |
	| Objectivity  | 6    | Balanced reporting with comprehensive analysis.    |
	| Social Impact | 5     | Significant influence on public opinion regarding health.    |
	| Credibility    | 5    | Solid evidence from authoritative sources.    |
	| Potential    | 5    | High potential to prevent a bird flu pandemic.    |
	| Practicality    | 4    | Highly practical for real-world health issues.    |
	| Entertainment Value    | 2    | Minimal entertainment value, primarily informative.    |
</TabItem>
</Tabs>

[Full article>>](https://www.cnbc.com/2024/07/02/us-awards-moderna-176-million-to-produce-bird-flu-vaccine.html)
